Overview
The actively managed equity fund focused on bottom-up active stock selection within Europe.
The fund aims to invests in selected European companies, that trade below their long term fair values based on fundamental analysis.
Exposure to the European market is ensured via diversification across various countries and sectors.
Actively managed fund based on a concentrated portfolio of attractively valued stocks.
The portfolio manager is not tied to the benchmark in terms of investment selection or weight.
Benefits
Easy access to European equity markets
The portfolio may deviate sharply from the reference index in order to increase outperformance potential.
The fund managers can also tap into the knowledge and experience of a network of equity analysts around the globe.
Investors benefit from the fact that UBS is one of the few asset managers with a truly global investment platform.
Risks
Features
| Product category |
Equity Europe |
| Product domicile |
Luxembourg
|
| Portfolio management |
UBS SA国际传谋 (UK) Ltd., London
|
| Fund management |
UBS SA国际传谋 (Europe) S.A., Luxembourg
|
| Custodian bank |
UBS Europe SE, Luxembourg Branch
|
| Representative for products established under foreign law |
UBS Fund Management (Switzerland) AG
|
| Day of inception |
September 16, 2019
|
| Currency of account |
EUR
|
| Close of financial year |
September 30
|
| SFDR Classification |
Art.8
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.11% p.a.
|
| Flat fee |
0.07% p.a.
|
| Management fee |
0.00% p.a.
|
| Total expense ratio (TER) |
0.10% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
MSCI Europe (net div. reinv.)
|
| Cut-Off Time |
15:00h(CET)
|
| Securities no. |
814705
|
| ISIN |
LU0421770834
|
| Bloomberg Ticker |
UBSECEE LX
|
Performance and Prices
Percentage growth
as of April 23, 2026| EUR(%) | CHF(%) | USD(%) | |
| YTD | 8.87 | 7.38 | 8.56 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 25.63 | 24.56 | 42.49 |
| 3Y | |||
| 5Y | 114.63 | 78.29 | 108.60 |
| ø p.a.5Y | 16.50 | 12.26 | 15.84 |
Current data
| Net asset value | 23.04.2026 | EUR 233.52 |
| High - last 12 months | 25.02.2026 | EUR 240.05 |
| Low - last 12 months | 24.04.2025 | EUR 177.14 |
| Assets of the unit class in mn | 23.04.2026 | EUR 204.21 |
| Total product assets in mn | 23.04.2026 | EUR 574.43 |
|
Date
|
2 years
|
5 years
|
|
| Total risk reference index / benchmark | 31.03.2026 | 10.60% | 12.32% |
| Sharpe Ratio | 31.03.2026 | 1.26 | 0.99 |
| Risk Free Rate | 31.03.2026 | 2.75% | 1.89% |
Structures
10 largest positions short (in %) (in %, as of March 31, 2026)
|
|
|
| Forvia SE | 0.45 |
| Novo Nordisk A/S | 0.65 |
| BAWAG Group AG | 0.86 |
| Wolters Kluwer NV | 1.02 |
| HUGO BOSS AG | 1.14 |
| Galp Energia SGPS SA | 1.20 |
| Symrise AG | 1.21 |
| Rio Tinto PLC | 1.28 |
| 3i Group PLC | 1.33 |
| Commerzbank AG | 1.36 |
Fees
Distributions
Sales Authorisations
Literature
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Key Information Document |
|
|
|
|
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
| Statutes / Management regulations |
|
|
||
| ESG Disclosure |
|
|||
| SFDR Pre-Contractual Annex |
|
|
Document type
|
Document Language
|
||
| Annual report |
|
|
|
| Semi-annual report |
|
|
|